Real-time enrollment status for this myelodysplastic syndromes clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 1:15 PM UTC
| NCT Number | NCT05308264 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic Syndromes |
| Phase | PHASE1 |
| Target Enrollment | 86 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Rigel Pharmaceuticals |
| Last Updated on CT.gov | August 10, 2026 (3 weeks ago) |
As of August 31, 2026: Clinical trial NCT05308264 is currently recruiting participants. This phase1 study for myelodysplastic syndromes is actively seeking new participants at 15 locations across the United States. The study is sponsored by Rigel Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05308264 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05308264 was last updated 3 weeks ago (August 10, 2026). HelloStudys verifies this status automatically.